These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1663407)

  • 1. Transforming growth factor-beta and the immune system.
    Ruscetti FW; Palladino MA
    Prog Growth Factor Res; 1991; 3(2):159-75. PubMed ID: 1663407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of transforming growth factor-beta on cells of the immune system.
    Ruscetti F; Varesio L; Ochoa A; Ortaldo J
    Ann N Y Acad Sci; 1993 Jun; 685():488-500. PubMed ID: 8363258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta: a bidirectional regulator of hematopoietic cell growth.
    Keller JR; Jacobsen SE; Dubois CM; Hestdal K; Ruscetti FW
    Int J Cell Cloning; 1992 Jan; 10(1):2-11. PubMed ID: 1552222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of immune responses by TGF-beta.
    Letterio JJ; Roberts AB
    Annu Rev Immunol; 1998; 16():137-61. PubMed ID: 9597127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta: recent advances on its role in immune tolerance.
    Mantel PY; Schmidt-Weber CB
    Methods Mol Biol; 2011; 677():303-38. PubMed ID: 20941619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-beta inhibits human antigen-specific CD4+ T cell proliferation without modulating the cytokine response.
    Tiemessen MM; Kunzmann S; Schmidt-Weber CB; Garssen J; Bruijnzeel-Koomen CA; Knol EF; van Hoffen E
    Int Immunol; 2003 Dec; 15(12):1495-504. PubMed ID: 14645158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta (TGF-beta).
    Clark DA; Coker R
    Int J Biochem Cell Biol; 1998 Mar; 30(3):293-8. PubMed ID: 9611771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
    Prud'homme GJ; Piccirillo CA
    J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI
    Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance.
    Verbanac KM; Carver FM; Haisch CE; Thomas JM
    Transplantation; 1994 Mar; 57(6):893-900. PubMed ID: 8154038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta-based immunotherapy for cancer: breaching the tumor firewall.
    Shah AH; Lee C
    Prostate; 2000 Oct; 45(2):167-72. PubMed ID: 11027416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of transforming growth factor beta (TGF beta) in systemic autoimmunity.
    Del Giudice G; Crow MK
    Lupus; 1993 Aug; 2(4):213-20. PubMed ID: 8268968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta: an important mediator of immunoregulation.
    Kehrl JH
    Int J Cell Cloning; 1991 Sep; 9(5):438-50. PubMed ID: 1955735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factors-beta as regulators of cellular growth and phenotype.
    Laiho M; Keski-Oja J
    Crit Rev Oncog; 1992; 3(1-2):1-26. PubMed ID: 1312867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones.
    Grégoire M; Garrigue L; Blottière HM; Denis MG; Meflah K
    Invasion Metastasis; 1992; 12(3-4):185-96. PubMed ID: 1338201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms.
    Turley JM; Falk LA; Ruscetti FW; Kasper JJ; Francomano T; Fu T; Bang OS; Birchenall-Roberts MC
    Cell Growth Differ; 1996 Nov; 7(11):1535-44. PubMed ID: 8930403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK
    Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TGF-beta in immune-evasion of cancer.
    Beck C; Schreiber H; Rowley D
    Microsc Res Tech; 2001 Feb; 52(4):387-95. PubMed ID: 11170297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.